HK1210951A1 - Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy - Google Patents

Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy Download PDF

Info

Publication number
HK1210951A1
HK1210951A1 HK15111764.4A HK15111764A HK1210951A1 HK 1210951 A1 HK1210951 A1 HK 1210951A1 HK 15111764 A HK15111764 A HK 15111764A HK 1210951 A1 HK1210951 A1 HK 1210951A1
Authority
HK
Hong Kong
Prior art keywords
cyclosporin
derivative
meala
etval
meleu
Prior art date
Application number
HK15111764.4A
Other languages
English (en)
Chinese (zh)
Inventor
保羅．伯納迪
保罗．伯纳迪
格里哥爾．弗格尼奧克斯
格里哥尔．弗格尼奥克斯
拉斐爾．克萊博
拉斐尔．克莱博
Original Assignee
德比奥法姆国际股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 德比奥法姆国际股份有限公司 filed Critical 德比奥法姆国际股份有限公司
Publication of HK1210951A1 publication Critical patent/HK1210951A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A61K38/13—Cyclosporins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
HK15111764.4A 2007-01-04 2010-05-20 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy HK1210951A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87841407P 2007-01-04 2007-01-04
US60/878,414 2007-01-04

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
HK10104988.4A Addition HK1137364A (en) 2007-01-04 2008-01-03 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy

Related Child Applications (1)

Application Number Title Priority Date Filing Date
HK10104988.4A Division HK1137364A (en) 2007-01-04 2008-01-03 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy

Publications (1)

Publication Number Publication Date
HK1210951A1 true HK1210951A1 (en) 2016-05-13

Family

ID=39514754

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15111764.4A HK1210951A1 (en) 2007-01-04 2010-05-20 Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy

Country Status (12)

Country Link
US (1) US8450281B2 (enExample)
EP (1) EP2124992A2 (enExample)
JP (1) JP5801534B2 (enExample)
CN (2) CN105056207A (enExample)
AU (1) AU2008204344B2 (enExample)
BR (1) BRPI0806265A2 (enExample)
CA (1) CA2674296C (enExample)
HK (1) HK1210951A1 (enExample)
IL (1) IL199674A (enExample)
MX (1) MX2009007045A (enExample)
RU (1) RU2462262C2 (enExample)
WO (1) WO2008084368A2 (enExample)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy
BR112012019866A8 (pt) 2010-02-09 2017-12-26 Biotica Tech Limited Composto, uso do mesmo, composição farmacêutica, e, processo para preparar um composto
WO2011098805A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
WO2011098808A1 (en) 2010-02-09 2011-08-18 Biotica Technology Limited Sanglifehrin based compounds
GB201008123D0 (en) 2010-05-17 2010-06-30 Biotica Tech Ltd Novel compounds
EP2654753B1 (en) 2010-12-20 2018-10-31 Neurovive Pharmaceutical AB Sanglifehrin derivatives and methods for their production
JO3063B1 (ar) 2011-03-29 2017-03-15 Neurovive Pharmaceutical Ab مركب مبتكر وطرق لانتاجه
WO2013169616A1 (en) 2012-05-07 2013-11-14 Novartis Ag Pharmacokinetic modulation with alisporivir
AR090964A1 (es) 2012-05-09 2014-12-17 Novartis Ag Proceso para la elaboracion de undecapeptidos ciclicos

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3884470T2 (de) * 1987-06-17 1994-03-10 Sandoz Ag Cyclosporine und deren Benutzung als Arzneimittel.
KR0148748B1 (ko) 1988-09-16 1998-08-17 장 크라메르, 한스 루돌프 하우스 사이클로스포린을 함유하는 약학조성물
EP1071414A1 (en) * 1998-04-24 2001-01-31 Mitokor Compounds and methods for treating mitochondria-associated diseases
AU759480B2 (en) * 1998-07-01 2003-04-17 Debiopharm S.A. Novel cyclosporin with improved activity profile
US6323039B1 (en) * 1999-06-22 2001-11-27 Mitokor Compositions and methods for assaying subcellular conditions and processes using energy transfer
US7368423B1 (en) 2001-12-05 2008-05-06 The Scripps Research Institute Composition and method for treating chronic allograft rejection
GB0320638D0 (en) * 2003-09-03 2003-10-01 Novartis Ag Organic compounds
WO2009098533A1 (en) * 2008-02-08 2009-08-13 Debiopharm Sa Non -immunosuppressive cyclosporin for the treatment of muscular dystrophy

Also Published As

Publication number Publication date
US8450281B2 (en) 2013-05-28
RU2009129212A (ru) 2011-02-10
CA2674296C (en) 2015-11-24
RU2462262C2 (ru) 2012-09-27
CN105056207A (zh) 2015-11-18
IL199674A0 (en) 2010-04-15
AU2008204344B2 (en) 2013-01-31
CN101616683A (zh) 2009-12-30
WO2008084368A9 (en) 2009-02-26
EP2124992A2 (en) 2009-12-02
AU2008204344A9 (en) 2012-06-28
CA2674296A1 (en) 2008-07-17
WO2008084368A2 (en) 2008-07-17
IL199674A (en) 2016-10-31
JP2010514834A (ja) 2010-05-06
MX2009007045A (es) 2009-10-07
JP5801534B2 (ja) 2015-10-28
WO2008084368A8 (en) 2009-09-17
US20100041593A1 (en) 2010-02-18
AU2008204344A1 (en) 2008-07-17
BRPI0806265A2 (pt) 2011-09-06

Similar Documents

Publication Publication Date Title
HK1210951A1 (en) Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy
JP3089350B2 (ja) シクロフィリンロタマーゼ活性の阻害剤
AU2011316690B2 (en) Cyclosporin analogs
KR20070036127A (ko) 알츠하이머병을 치료하기 위한 사이클로스포린
ES2558710T3 (es) Ciclosporina no inmunosupresora para el tratamiento de distrofia muscular del anillo óseo
KR20070009674A (ko) 대뇌 허혈 및 뇌와 척수 상해에서의 ｎｉｍ８１１
HK1137364A (en) Non-immunosuppressive cyclosporin for treatment of ullrich congenital muscular dystrophy
WO2023083718A1 (fr) Phytoecdysones et/ou dérivés de 20-hydroxyecdysone en combinaison avec un principe actif visant à restaurer l'expression smn pour leur utilisation dans le traitement de l'amyotrophie spinale
WO2004075888A1 (ja) 角膜潰瘍治療剤
Hunt et al. Cyclosporin A enhances cell survival in neural precursor populations in the adult central nervous system
Corbetta Horizontal tunnelling nanotube transfer to rescue dysfunctional mitochondria in diabetic nephropathy
Guo et al. Oxidative Stress-Induced Mitochondrial Damage Aggravates M1 Macrophage Polarization by Activating the Cgas–Sting-Nf-Κb Signaling Axis in Autoimmune Uveitis
Herink et al. Antiacetylcholinesterase activity of cyclosporine-A comparison of single and repeated administration and effect of 7-methoxytacrine
JPH0717677B2 (ja) “８−アミノ酸”に改良のある新規シクロスポリン誘導体
HK1148665B (en) Non-immunosuppressive cyclosporin for the treatment of muscular dystrophy